165 related articles for article (PubMed ID: 28935813)
1. ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.
Shukla V; Rao M; Zhang H; Beers J; Wangsa D; Wangsa D; Buishand FO; Wang Y; Yu Z; Stevenson HS; Reardon ES; McLoughlin KC; Kaufman AS; Payabyab EC; Hong JA; Zhang M; Davis S; Edelman D; Chen G; Miettinen MM; Restifo NP; Ried T; Meltzer PA; Schrump DS
Cancer Res; 2017 Nov; 77(22):6267-6281. PubMed ID: 28935813
[TBL] [Abstract][Full Text] [Related]
2. ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.
Szczepanski AP; Zhao Z; Sosnowski T; Goo YA; Bartom ET; Wang L
Genome Med; 2020 Jul; 12(1):63. PubMed ID: 32669118
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer.
Tsuboyama N; Wang R; Szczepanski AP; Chen H; Zhao Z; Shi L; Wang L
Oncogene; 2022 Apr; 41(15):2152-2162. PubMed ID: 35194152
[TBL] [Abstract][Full Text] [Related]
4. Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy.
Wang Q; Zeng F; Sun Y; Qiu Q; Zhang J; Huang W; Huang J; Huang X; Guo L
Clin Cancer Res; 2018 Feb; 24(4):950-962. PubMed ID: 29208667
[No Abstract] [Full Text] [Related]
5. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts.
Hansen M; Varga E; Wüst T; Brouwer N; Beauchemin H; Mellink C; van der Kevie-Kersemaekers AM; Möröy T; van der Reijden B; von Lindern M; van den Akker E
Stem Cell Res; 2017 Jan; 18():26-28. PubMed ID: 28395797
[TBL] [Abstract][Full Text] [Related]
7. Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity.
Udyavar AR; Wooten DJ; Hoeksema M; Bansal M; Califano A; Estrada L; Schnell S; Irish JM; Massion PP; Quaranta V
Cancer Res; 2017 Mar; 77(5):1063-1074. PubMed ID: 27932399
[TBL] [Abstract][Full Text] [Related]
8. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
[TBL] [Abstract][Full Text] [Related]
9. Cultured Cells from the Human Oocyte Cumulus Niche Are Efficient Feeders to Propagate Pluripotent Stem Cells.
Assou S; Pourret E; Péquignot M; Rigau V; Kalatzis V; Aït-Ahmed O; Hamamah S
Stem Cells Dev; 2015 Oct; 24(19):2317-27. PubMed ID: 26153797
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.
Lopez-Onieva L; Montes R; Lamolda M; Romero T; Ayllon V; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
Stem Cell Res; 2016 May; 16(3):692-5. PubMed ID: 27346198
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in Small Cell Lung Cancer.
Shukla V; Wang H; Varticovski L; Baek S; Wang R; Wu X; Echtenkamp F; Hernandez FV; Prothro KP; Gara SK; Zhang MR; Shiffka S; Raziuddin R; Neckers LM; Linehan WM; Chen H; Hager GL; Schrump DS
J Thorac Oncol; 2024 Apr; ():. PubMed ID: 38583771
[TBL] [Abstract][Full Text] [Related]
12. Generation of an induced pluripotent stem cell line from a patient with chronic myeloid leukemia (CML) resistant to targeted therapies.
Telliam G; Féraud O; Griscelli F; Opolon P; Divers D; Bennaceur-Griscelli A; Turhan AG
Stem Cell Res; 2016 Sep; 17(2):235-237. PubMed ID: 27879209
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
[TBL] [Abstract][Full Text] [Related]
14. Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T).
Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
Stem Cell Res; 2016 Sep; 17(2):205-207. PubMed ID: 27879207
[TBL] [Abstract][Full Text] [Related]
15. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
[TBL] [Abstract][Full Text] [Related]
16. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
Horie M; Miyashita N; Mattsson JSM; Mikami Y; Sandelin M; Brunnström H; Micke P; Nagase T; Saito A
J Pathol; 2018 Oct; 246(2):154-165. PubMed ID: 29876935
[TBL] [Abstract][Full Text] [Related]
17. Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells.
Kudoh S; Tenjin Y; Kameyama H; Ichimura T; Yamada T; Matsuo A; Kudo N; Sato Y; Ito T
Histochem Cell Biol; 2020 Jun; 153(6):443-456. PubMed ID: 32170367
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
[TBL] [Abstract][Full Text] [Related]
19. Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells.
Coles GL; Cristea S; Webber JT; Levin RS; Moss SM; He A; Sangodkar J; Hwang YC; Arand J; Drainas AP; Mooney NA; Demeter J; Spradlin JN; Mauch B; Le V; Shue YT; Ko JH; Lee MC; Kong C; Nomura DK; Ohlmeyer M; Swaney DL; Krogan NJ; Jackson PK; Narla G; Gordan JD; Shokat KM; Sage J
Cancer Cell; 2020 Jul; 38(1):129-143.e7. PubMed ID: 32531271
[TBL] [Abstract][Full Text] [Related]
20. Involvement of intermediate filament nestin in cell growth of small-cell lung cancer.
Takakuwa O; Maeno K; Kunii E; Ozasa H; Hijikata H; Uemura T; Kasai D; Ohkubo H; Miyazaki M; Oguri T; Niimi A
Lung Cancer; 2013 Aug; 81(2):174-9. PubMed ID: 23706418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
